Stratos Wealth Partners, Ltd. Pds Biotechnology Corp Put Options Transaction History
Stratos Wealth Partners, Ltd.
- $7.06 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
58Shares Held
7.69MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.17 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.89 Million0.0% of portfolio
-
Ubs Group Ag543KShares$526,7300.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$472,3570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$405,3950.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $27.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...